Molecular Weight
4963 Da
Half-Life
7-14 days
Evidence Passport
Evidence strength, status, identity, route and safety are scored separately.
Human evidence
Human source linked; classification pending
A human source exists, but its strength and applicability have not completed review.
Development status
Preclinical development
Investigational development is not the same as approval or product suitability.
Identity match
Named compound linked
Sources are linked to the named compound; formulation and product quality remain separate questions.
Route relevance
Route match not verified
Catalogue route: Subcutaneous or intramuscular injection. A matching human study route is not confirmed.
Safety record
6 documented flags
Documented flags are visible, but absence of a listed risk would not prove safety.
2 app-verified sources linked · Version 2026-08-31
Synthetic derivative of Thymosin Beta-4 (TB-4). Promotes angiogenesis, cell migration, and tissue repair through actin-binding properties. Demonstrated tissue repair benefits in preclinical models.
These topics describe the catalogue's research index. They are not promised outcomes or personal recommendations.
Thymosin beta-4 cardiac repair (2012)
Promoted cardiac repair following myocardial infarction in mice
DOI: 10.1161/CIRCULATIONAHA.112.103648Explore more peptides in this category
View All Healing Peptides →Research Disclaimer: This information is compiled from published research and is provided for educational purposes only. Peptides discussed here are classified as research chemicals in most jurisdictions and are not FDA-approved for human use unless otherwise noted. Consult a qualified healthcare provider before starting any protocol.